Operative Treatment vs Treatment With Semi-occlusive Dressing for Single Finger Amputations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTampere University Hospital

About this trial

The goal of this interventional study is to find out whether conservative treatment with semi-occlusive film is superior to surgical treatment in single finger amputations in adult population. The main question it aims to answer is:

Is PRWHE (Patient Reported Wrist and Hand Evaluation) total score measured at 12 months after injury better in conservatively or operatively treated patients?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age >18, single digit injury, Amputation at Tamai zones 1+2 in all digits or Tamai zones 3+4 in digits II-V, Able to understand Finnish and to complete self-reported questionnaires

Disqualifiers

Previous partial or total amputation of the injured digit, Previous condition which affects significantly the function and/or symptoms of the affected hand, Patient is pregnant at the time of recruitment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Operative treatment of surgeons choice

    Procedure/Surgery

    treatment of single finger amputation with revision amputation, local or micro-vascular flap as best befits each specific injury

  • Semi-occlusive film

    Procedure/Surgery

    The film is placed on a cleansed wound surface. bone is shortened to the level of injury. Visible nerves, arteries and tendons are cut and allowed to retract. The film is to be changed once weekly until the wound has closed.

Treatment groups

252 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: Tamai zone 1 operativeActive comparator 1 intervention
Group B: Tamai Zone 1 non-operativeExperimental treatment 1 intervention
Group C: Tamai zone 2 operativeActive comparator 1 intervention
Group D: Tamai Zone 2 non-operativeExperimental treatment 1 intervention
Group E: Tamai Zone 3-4 operative (fingers II-V)Active comparator 1 intervention
Group F: Tamai Zone 3-4 non-operative (fingers II-V)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

PRWHE

Our primary outcome measure is PRWHE mean difference (MD) between treatment arms in each stratum with the associated 95% confidence interval (CI) at 12 months post-randomization. Patient-Reported Wrist and Hand Evaluation (PRWHE) was chosen, because it covers both pain and loss of function which are the main symptoms after a digital amputation, has evidence of reliability, validity and responsiveness in hand and wrist trauma population, and is considered slightly more responsive than DASH. As a patient reported outcome, it is prone to ascertainment bias - especially since in this study setting it is not possible to blind the participant to given treatment. To overcome this, we have included several objective outcome measures as secondary outcomes. Nevertheless, Patient-Reported Outcome Measures are considered the most meaningful instruments for outcome evaluation in musculoskeletal conditions, because those assess patient-perceived important symptoms and disability.

Time frame
12 months

Secondary outcomes

1

PRWHE 1 month

PRWHE mean difference (MD) between treatment arms in each stratum with the associated 95% confidence interval (CI) at 1 month post-randomization.

Time frame
1 month
2

PRWHE 3 months

PRWHE mean difference (MD) between treatment arms in each stratum with the associated 95% confidence interval (CI) at 3 months post-randomization.

Time frame
3 months
3

PRWHE 6 months

PRWHE mean difference (MD) between treatment arms in each stratum with the associated 95% confidence interval (CI) at 6 months post-randomization.

Time frame
6 months
4

Return to daily activities 1 month

return to daily activities is collected at 1, 3, 6, and 12 months. Amputation injuries are significant indicators for being off work and having a prolonged time off work. Potential difference between treatment arms in Return to ordinary daily activities could have wider economic implications and work as a factor in determining the most beneficial treatment option for each patient.

Time frame
1 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.